Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors

Heart failure is associated with a substantial risk of mortality and morbidity. Findings from recent cardiovascular outcome trials have shown promise for sodium-glucose cotransporter-2 (SGLT2) inhibitors in preventing heart failure in patients with type 2 diabetes mellitus (T2DM). Notably, the benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Liwen, Gao, Xiufang, Xie, Kun, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494970/
https://www.ncbi.nlm.nih.gov/pubmed/34631819
http://dx.doi.org/10.3389/fcvm.2021.716083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494970/
https://www.ncbi.nlm.nih.gov/pubmed/34631819
http://dx.doi.org/10.3389/fcvm.2021.716083

Ejemplares similares